Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Biographical Sketch
Beth Leventhal Fromkin, MD was born and raised in Brooklyn, NY. She has been with Cleveland Clinic Florida in the Department of Nephrology since 2001.
She is a graduate of Stuyvesant High School and Princeton University. She attended medical school at Albert Einstein College of Medicine of Yeshiva University in Bronx, NY. She completed her internal medicine Residency at Yale-New Haven Hospital in New Haven, CT and completed her fellowship in Nephrology at NY Presbyterian Hospital Cornell Medical Center in New York, NY. After completing her nephrology fellowship, she then completed a second fellowship in Hypertension at NY Presbyterian Hospital Cornell Medical Center in New York, NY. She is board certified in Nephrology by the American Board of Internal Medicine and is also board certified in Hypertension by the American Society of Hypertension. She is currently one of only 46 board certified hypertension specialists in the State of Florida.
Dr. Beth Fromkin specializes in all aspects of inpatient and outpatient kidney disease and has expertise in renal transplant medicine. She treats complex and secondary causes of hypertension. She performs hemodialysis, peritoneal dialysis, CVV-H, and CVV-HD. She performs kidney biopsies and treats vasculitis and nephritis. She is an active teacher in the Department's fully accredited Nephrology fellowship program. She is active in the Princeton University Alumni Association.
Specialty Interests
Chronic kidney disease, dialysis, dialysis chronic kidney disease, dialysis and kidney biopsy, end stage renal disease, general nephrology, glomerulonephritis, hypertension, predialysis care, renal biopsies, renal diseases, renal transplantation medicine
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 7/5/2012, Dr. Fromkin has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.